Each year, healthcare organizations, schools, governments, companies, and communities around the world observe World Antibiotic Awareness Week (WAAW).
World Antimicrobial Awareness Week 2020 Toolkit
COVID-19 and Antimicrobial Resistance: Dual Health Threats
Each year, more than 700,000 people lose their lives to drug-resistant infections, and this number could climb to 10 million by the year 2050 if nothing is done help combat it. Now, the COVID-19 pandemic is exacerbating the problem.
How do the COVID-19 tests and molecular tests work?
Amid the spread of COVID-19, testing for SARS-COV-2, the virus that causes it, is at the forefront of the battle. Patients rely on test results to confirm if they’ve acquired the coronavirus, and public health entities around globe rely on the data to learn how and where the virus is spreading.
Managing the Risks of Antimicrobial Resistance Concurrently with COVID-19
Patients at the greatest risk for secondary infections, particularly infections that are resistant to first-line antibiotics, include people who are already vulnerable due to other conditions and diseases—like COVID-19. Because of that, antimicrobial resistance poses a significant additional threat, especially as healthcare systems become overburdened.
World Antimicrobial Awareness Week 2020 Toolkit
Each year, healthcare organizations, schools, governments, companies, and communities around...
COVID-19 and Antimicrobial Resistance: Dual Health Threats
Each year, more than 700,000 people lose their lives to...